Beginning Cash: The amount of cash reported by the company on its previous statement.
BRIACELL THERAP (BCTX) had Beginning Cash of $10.49M for the most recently reported fiscal quarter, ending 2026-01-31.
| Income Statement Financials | |
-- |
|
$-7.22M |
|
-- |
|
-- |
|
$7.53M |
|
$-7.53M |
|
$0.23M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-7.53M |
|
$-7.50M |
|
2.80M |
|
2.80M |
|
$-2.58 |
|
$-2.58 |
|
| Balance Sheet Financials | |
$32.18M |
|
$0.25M |
|
$1.42M |
|
$33.59M |
|
$3.19M |
|
-- |
|
$0.20M |
|
$3.38M |
|
$30.21M |
|
$30.04M |
|
$30.21M |
|
7.25M |
|
| Cash Flow Statement Financials | |
$-15.67M |
|
$7.21M |
|
$27.87M |
|
|
Beginning Cash |
$10.49M |
$29.90M |
|
$19.41M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.15% |
|
-24.29% |
|
-21.72% |
|
-24.15% |
|
$4.17 |
|
$-5.59 |
|
$-5.59 |
|